Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
- Resource Type
- Article
- Source
- In
European Urology Oncology April 2024 - Subject
- Language
- ISSN
- 2588-9311